Orca Bio
Tony Cano is an accomplished professional with extensive experience in bioprocess and purification development. Currently serving as Executive Director of CMC Process Development at Orca Bio since September 2021, Tony has previously held key leadership positions, including Executive Director, Head of Purification Process Development at Sana Biotechnology, Inc., and Sr. Director of Process Sciences at AbbVie. Prior roles also include Director of Process Sciences at Stemcentrx and various positions at Genentech, culminating in a Group Leader role. Tony holds a Ph.D. in Chemical Engineering from the University of Houston and a Bachelor of Engineering in Chemical Engineering from Vanderbilt University.
This person is not in any teams
Orca Bio
3 followers
Orca Bio is a clinical-stage biotechnology company developing a pipeline of high precision allogeneic cell therapy products that are designed to safely replace patients’ diseased blood and immune system with a healthy one. Their manufacturing platform sorts donor blood with single-cell precision and a high level of purity and speed, enabling them to create proprietary, optimal therapeutic mixtures of immune and stem cells that have the potential to transform allogeneic cell therapy. Their talented team is driven by a passion for science and compassion for patients.